- Investing Ideas
- /
- Hong Kong Healthcare Undervalued based on future growth
Hong Kong Healthcare Undervalued based on future growth
Results
4
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
4 companies
LEPU ScienTech Medical Technology (Shanghai)
Market Cap: HK$7.7b
An investment holding company, engages in the manufacture and sale of interventional treatment series occluders for defective congenital heart disease.
2291
HK$22.14
7D
-0.8%
1Y
50.8%
OrbusNeich Medical Group Holdings
Market Cap: HK$3.6b
An investment holding company, engages in the manufacture, trading, sale, and marketing of medical devices/instruments for the treatment of coronary and peripheral vascular diseases.
6929
HK$4.39
7D
-8.2%
1Y
36.3%
Sisram Medical
Market Cap: HK$2.8b
Engages in the research, design, development, manufacture, sale, and marketing of medical aesthetics and dental equipment, home use devices, injectables, and cosmeceuticals products in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa.
1696
HK$5.99
7D
-5.7%
1Y
78.8%
Chaoju Eye Care Holdings
Market Cap: HK$1.8b
Owns and operates a network of ophthalmic hospitals and optical centers in China.
2219
HK$2.67
7D
-1.8%
1Y
-2.6%